Q2 EPS Estimates for Ardent Health Cut by Leerink Partnrs

Ardent Health, Inc. (NYSE:ARDT - Free Report) - Research analysts at Leerink Partnrs lowered their Q2 2025 earnings estimates for Ardent Health in a research report issued to clients and investors on Monday, June 23rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $0.22 for the quarter, down from their prior forecast of $0.59. The consensus estimate for Ardent Health's current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health's Q3 2025 earnings at $0.81 EPS.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion. Ardent Health had a return on equity of 16.07% and a net margin of 3.73%.

A number of other equities analysts have also commented on ARDT. Royal Bank Of Canada reiterated an "outperform" rating and issued a $21.00 target price on shares of Ardent Health in a report on Thursday, May 15th. Mizuho dropped their price objective on Ardent Health from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Guggenheim lifted their target price on Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Finally, Stephens reissued an "overweight" rating and issued a $21.00 price target on shares of Ardent Health in a research note on Tuesday, May 20th. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $20.67.

Ardent Health Trading Up 2.0%

Shares of NYSE ARDT traded up $0.27 during trading on Thursday, reaching $13.58. The company had a trading volume of 50,892 shares, compared to its average volume of 385,600. The stock has a market cap of $1.94 billion and a P/E ratio of 8.33. The company's fifty day moving average price is $13.73 and its 200-day moving average price is $14.30. The company has a quick ratio of 1.98, a current ratio of 2.12 and a debt-to-equity ratio of 0.70. Ardent Health has a 12 month low of $11.31 and a 12 month high of $20.72.

Hedge Funds Weigh In On Ardent Health

Hedge funds have recently modified their holdings of the company. Rhumbline Advisers grew its holdings in shares of Ardent Health by 23.9% in the fourth quarter. Rhumbline Advisers now owns 16,913 shares of the company's stock valued at $289,000 after acquiring an additional 3,266 shares in the last quarter. New York State Common Retirement Fund bought a new position in Ardent Health in the 4th quarter valued at $48,000. Bank of New York Mellon Corp increased its position in shares of Ardent Health by 8.2% during the 4th quarter. Bank of New York Mellon Corp now owns 25,615 shares of the company's stock valued at $438,000 after purchasing an additional 1,941 shares during the last quarter. US Bancorp DE purchased a new stake in shares of Ardent Health during the 4th quarter valued at $31,000. Finally, Sei Investments Co. raised its stake in shares of Ardent Health by 27.7% during the 4th quarter. Sei Investments Co. now owns 176,866 shares of the company's stock worth $3,021,000 after purchasing an additional 38,347 shares during the period.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.